A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
Clinical trial NCT02453256 · COMPLETED
Trial details
- NCT number
- NCT02453256
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-20
- Primary completion
- 2018-01-15
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.